Chartwell RX LLC — Federal Contractor Profile
Chartwell RX LLC holds two large federal contracts totaling $198.1 million.
Contractor Overview
Total Contract Value: $2,674,281,692 ($2.7B)
Total Awards: 27
Company Profile
CHARTWELL RX LLC operates within the federal contracting landscape primarily as a supplier of pharmaceutical products. Their core capabilities revolve around the procurement, distribution, and potentially the manufacturing or repackaging of medications for government entities. The scale of their government business, as indicated by a total contract value of $198.1 million across two contracts, suggests a significant, albeit focused, engagement with federal agencies. The average contract size of approximately $99 million points to large-scale, potentially long-term agreements. Without specific agency client data, it's challenging to pinpoint their exact relationship with particular departments, but such substantial contracts typically serve agencies with significant healthcare or medical support needs, such as the Department of Defense (DoD) or the Department of Veterans Affairs (VA). The limited number of contracts (two) and the absence of recent contract data make it difficult to ascertain their win patterns (competitive vs. sole-source) or their track record with specific projects. However, the substantial value of these contracts implies they likely secured them through a competitive bidding process or as a sole-source provider for specialized pharmaceutical needs. The contract patterns, with two large contracts, suggest a strategy focused on securing major supply agreements rather than a broad portfolio of smaller engagements. This approach allows them to concentrate resources and expertise on fulfilling large-scale pharmaceutical requirements for the government.
Specializations
- Pharmaceutical Supply
- Medication Procurement
- Government Healthcare Support
- Drug Distribution
- Medical Supply Chain Management
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: Unknown
Agency Concentration: Unknown
Growth Trajectory: Unknown
Competitive Position
Given the limited public data, Chartwell RX LLC's competitive position is difficult to definitively assess. The substantial value of their contracts suggests they are capable of competing for and fulfilling large-scale pharmaceutical supply needs. However, without knowing the number of bids they typically submit or the nature of the competition for these specific contracts, it's unclear if they are a dominant player, a niche specialist, or one among many suppliers in this sector.
Value to Taxpayers
The value Chartwell RX LLC provides to taxpayers is primarily through the reliable supply of pharmaceuticals to government entities. The significant contract values indicate they are fulfilling substantial needs. However, without more information on their win rates, pricing structures, and performance metrics for these contracts, a definitive assessment of 'good value' is not possible. The lack of recent contract data also hinders an evaluation of their ongoing performance and adaptability.
Agency Relationships
The specific agencies that rely most on Chartwell RX LLC are not detailed in the provided data. However, contracts of this magnitude for pharmaceuticals are typically awarded to support the healthcare needs of large federal populations, such as those served by the Department of Veterans Affairs or the Department of Defense. Without more information, it's impossible to assess dependency risks.
Red Flags
- Limited contract data: Only two contracts are listed, making it difficult to assess the breadth and consistency of their government business.
- Lack of recent activity: No recent contracts are available, which could indicate a shift in strategy, reduced government focus, or simply a gap in reporting.
Green Flags
- Significant contract values: The two contracts are substantial, indicating the company's capacity to handle large-scale government requirements.
- Potential for essential services: Pharmaceutical supply is a critical government function, suggesting the company plays a vital role in supporting federal health initiatives.
Key Contracts
Chartwell RX LLC's government contracting profile is defined by two substantial contracts, collectively valued at $198.1 million. The average value of these contracts stands at an impressive $99,047,470, indicating that the company has secured significant agreements with federal agencies. The nature of these contracts, given the company's specialization in pharmaceuticals, strongly suggests they are involved in the large-scale procurement and supply of medications. Such large contracts are typically awarded to meet the extensive healthcare needs of federal populations, potentially serving departments like the Department of Veterans Affairs (VA) or the Department of Defense (DoD), which manage vast healthcare systems. The sheer size of these awards implies that Chartwell RX LLC possesses the logistical capabilities, supply chain management expertise, and potentially the product portfolio necessary to fulfill complex and high-volume pharmaceutical requirements. The limited number of contracts, however, means that their government business is highly concentrated, focusing on securing major supply agreements rather than a diverse array of smaller projects. This strategy allows for deep engagement with specific needs but also presents a potential risk if these large contracts are not renewed or if government priorities shift away from the specific pharmaceutical areas they serve.
Frequently Asked Questions
What does CHARTWELL RX LLC do for the government?
CHARTWELL RX LLC primarily serves the government by supplying pharmaceutical products. Their core business involves the procurement, distribution, and potentially the management of medications required by federal agencies. Given the substantial value of their contracts, they likely provide large quantities of drugs to support federal healthcare programs, such as those administered by the Department of Veterans Affairs or the Department of Defense, ensuring that essential medications are available to government beneficiaries and personnel.
How much taxpayer money does CHARTWELL RX LLC receive?
CHARTWELL RX LLC has received a total of $198.1 million in federal contract funds across two contracts. The average value per contract is approximately $99,047,470. This figure represents the total obligated amount for these specific agreements, indicating the scale of their financial engagement with the government.
Is CHARTWELL RX LLC good value for taxpayer money?
Assessing the value for taxpayer money provided by CHARTWELL RX LLC is challenging with the available data. The company has secured two very large contracts, suggesting they can meet significant government needs. However, without insight into their competitive win rates, the specifics of their pricing, or performance metrics on these contracts, it's difficult to definitively state whether they offer optimal value. Further analysis of contract performance and comparison with other potential suppliers would be necessary for a comprehensive evaluation.
How does CHARTWELL RX LLC win its contracts?
The provided data does not explicitly detail how CHARTWELL RX LLC wins its contracts. With only two contracts totaling $198.1 million, it's plausible they secured these through competitive bidding processes, especially given their substantial value. Alternatively, these could be sole-source awards if Chartwell RX LLC possesses unique capabilities or exclusive rights to certain pharmaceuticals. A deeper analysis of contract award types (e.g., competitive, sole-source, set-aside) would be needed to understand their win strategy.
What agencies use CHARTWELL RX LLC most?
The specific government agencies that are the primary clients for CHARTWELL RX LLC are not identified in the provided data. However, given the significant value of their contracts and their specialization in pharmaceuticals, it is highly probable that agencies with large healthcare operations, such as the Department of Veterans Affairs (VA) or the Department of Defense (DoD), are their main customers. These agencies manage extensive healthcare systems requiring substantial and consistent pharmaceutical supplies.